Perioperative nivolumab results in favourable long-term outcomes in patients with locally advanced resectable non-small-cell lung cancer

Nat Rev Clin Oncol. 2024 Dec 3. doi: 10.1038/s41571-024-00976-x. Online ahead of print.
No abstract available